Sylvia Cheung
Financieel Directeur/CFO bij OCULIS HOLDING AG
Vermogen: 785 662 $ op 31-05-2024
Actieve functies van Sylvia Cheung
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCULIS HOLDING AG | Financieel Directeur/CFO | 01-09-2020 | - |
| Public Communications Contact | 01-09-2020 | - |
Loopbaan van Sylvia Cheung
Eerdere bekende functies van Sylvia Cheung
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-10-2005 | 10-08-2020 |
| Financieel Directeur/CFO | 01-04-2013 | 10-08-2020 | |
| Investor Relations Contact | 01-10-2005 | 10-08-2020 | |
| Bedrijfssecretaris | 01-04-2013 | 04-03-2020 | |
| Treasurer | 01-04-2013 | 10-08-2020 | |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 01-01-2000 | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01-01-1995 | 01-01-2000 |
Opleiding van Sylvia Cheung
| University of Massachusetts | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Noorwegen | 2 |
| Zwitserland | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| OCULIS HOLDING AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Beurs
- Insiders
- Sylvia Cheung
- Ervaring
